Back to GetFilings.com





 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

(Mark one)

x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

     FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2003

 

OR

 

¨   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

     For the transition period from                      to             

 

Commission File Number: 000-30347

 


 

CURIS, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

(State or Other Jurisdiction

of Incorporation or Organization)

  

04-3505116

(I.R.S. Employer

Identification No.)

61 Moulton Street,

Cambridge, Massachusetts

(Address of Principal Executive Offices)

  

02138

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (617) 503-6500

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  Yes    ¨  No

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    ¨  Yes    x  No

 

As of July 31, 2003, there were 37,374,888 shares of the registrant’s common stock, $0.01 par value per share, outstanding.

 




CURIS, INC. AND SUBSIDIARIES

QUARTERLY REPORT ON FORM 10-Q

 

INDEX

 

PART I.

   FINANCIAL INFORMATION    Page
Number


Item 1.

   Financial Statements     
    

Condensed Consolidated Balance Sheets as of June 30, 2003 and December 31, 2002

     3
    

Consolidated Statements of Operations and Comprehensive Loss for the three- and six-month periods ended June 30, 2003 and 2002

     4
    

Consolidated Statements of Cash Flows for the six-month periods ended June 30, 2003 and 2002

     5
    

Notes to Condensed Consolidated Financial Statements

     6

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    13

Item 3.

   Quantitative and Qualitative Disclosures About Market Risk    35

Item 4.

   Controls and Procedures    35

PART II.

   OTHER INFORMATION     

Item 2.

   Changes in Securities and Use of Proceeds    36

Item 4.

   Submission of Matters to a Vote of Security Holders    36

Item 6.

   Exhibits and Reports on Form 8-K    37

SIGNATURE

   38

CERTIFICATION

    


PART I—FINANCIAL INFORMATION

 

Item 1.    FINANCIAL STATEMENTS

 

CURIS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)

 

    

June 30,

2003


    December 31,
2002


 

ASSETS

                

Current Assets:

                

Cash and cash equivalents

   $ 21,778,707     $ 26,920,605  

Cash and cash equivalents—restricted

     4,191,951       4,403,188  

Marketable securities

     8,791,060       9,652,671  

Due from joint venture

     —         1,299,289  

Other current assets

     5,680,812       1,386,817  
    


 


Total current assets

     40,442,530       43,662,570  
    


 


Property and Equipment, net

     3,022,418       3,775,269  
    


 


Other Assets:

                

Goodwill, net

     8,982,000       8,982,000  

Other intangible assets, net (Note 7)

     214,731       252,273  

Long-term notes receivable

     5,050,152       4,662,553  

Deposits and other assets

     1,567,762       1,107,028  
    


 


Total other assets

     15,814,645       15,003,854  
    


 


     $ 59,279,593     $ 62,441,693  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                

Current Liabilities:

                

Debt and lease obligations, current portion

   $ 4,748,321     $ 2,105,049  

Accounts payable

     529,891       726,092  

Accrued liabilities

     4,150,985       4,450,893  

Deferred revenue, current portion

     348,569       191,782  

Due to joint venture

     —         1,089,083  
    


 


Total current liabilities

     9,777,766       8,562,899  

Debt and Lease Obligations, net of current portion

     7,594       3,424,422  

Convertible Notes Payable

     5,145,096       6,885,486  

Deferred Revenue, net of current portion

     16,693,245       11,962,224  
    


 


       21,845,935       22,272,132  

Preferred Stock, $0.01 par value, 5,000,000 shares authorized—
Series A Convertible Exchangeable Preferred Stock—1,426 shares authorized; 0 and 1,000 shares issued and outstanding at June 30, 2003 and December 31, 2002, respectively

     —         13,064,283  
    


 


Commitments

                

Stockholders’ Equity:

                

Common stock, $0.01 par value—Authorized—125,000,000 shares at June 30, 2003 and December 31, 2002
Issued—37,360,056 and 32,329,228 shares at June 30, 2003 and December 31, 2002, respectively

     373,602       327,685  

Additional paid-in capital

     699,889,650       659,512,957  

Notes receivable

     (1,337,561 )     (1,337,561 )

Treasury stock (at cost, 1,047,707 and 1,022,207 shares at June 30, 2003 and December 31, 2002, respectively)

     (891,274 )     (869,384 )

Deferred compensation

     (1,505,423 )     (2,037,230 )

Accumulated deficit

     (668,872,786 )     (637,174,017 )

Accumulated other comprehensive income

     (316 )     119,929  
    


 


Total stockholders’ equity

     27,655,892       18,542,379  
    


 


     $ 59,279,593     $ 62,441,693  
    


 


 

See accompanying notes to unaudited consolidated financial statements

 

3


CURIS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited)

 

     Three Months Ended June 30,

    Six Months Ended June 30,

 
     2003

    2002

    2003

    2002

 

REVENUES:

                                

License fees and royalty revenue

   $ 63,485     $ 127,846     $ 112,192     $ 205,606  

Research and development contract revenue

     485,457       61,757       872,108       142,629  
    


 


 


 


       548,942       189,603       984,300       348,235  

COSTS AND EXPENSES (A):

                                

Research and development

     3,592,678       3,902,554       6,506,319       8,737,317  

General and administrative

     1,492,221       1,980,024       3,026,653       5,200,032  

Stock-based compensation

     655,328       427,433       919,194       1,124,895  

Amortization of intangible assets

     18,771       60,405       37,542       120,810  

Impairment of property and equipment

     —         164,842       —         5,336,785  

Impairment of goodwill

     —         64,098,345       —         64,098,345  

Realignment expenses

     —         —         —         3,490,000  
    


 


 


 


Total costs and expenses

     5,758,998       70,633,603       10,489,708       88,108,184  
    


 


 


 


Net loss from operations

     (5,210,056 )     (70,444,000 )     (9,505,408 )     (87,759,949 )
    


 


 


 


Equity in loss of joint venture

     —         (1,078,223 )     —         (2,239,906 )

Other income, net

     262,264       529,036       267,812       1,186,629  
    


 


 


 


Net loss

   $ (4,947,792 )   $ (70,993,187 )   $ (9,237,596 )   $ (88,813,226 )

Accretion of preferred stock dividend Net loss applicable to common stockholders

     (91,081 )     (180,225 )     (271,306 )     (362,453 )
    


 


 


 


     $ (5,038,873 )   $ (71,173,412 )   $ (9,508,902 )   $ (89,175,679 )
    


 


 


 


Net loss per common share—basic and diluted

   $ (0.15 )   $ (2.20 )   $ (0.29 )   $ (2.76 )
    


 


 


 


Weighted average common shares—basic and diluted

     33,501,511       32,334,965       32,621,151       32,332,113  
    


 


 


 


Net loss

   $ (4,947,792 )   $ (70,993,187 )   $ (9,237,596 )   $ (88,813,226 )

Unrealized loss on marketable securities

     (9,003 )     —         (23,648 )     (249,841 )
    


 


 


 


Comprehensive loss

   $ (4,956,795 )   $ (70,993,187 )   $ (9,261,244 )   $ (89,063,067 )
    


 


 


 


(A)   The following summarizes the departmental allocation of the stock-based compensation charge:

                                

Research and development

   $ 543,302     $ 311,323     $ 729,227     $ 649,790  

General and administrative

     112,026       116,610       189,967       475,605  
    


 


 


 


Total stock-based compensation

   $ 655,328     $ 427,933     $ 919,194     $ 1,125,395  
    


 


 


 


 

See accompanying notes to unaudited consolidated financial statements

 

4


CURIS, INC. AND SUBSIDIARIES 

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

 

<
     Six-Months Ended June 30,

 
     2003

    2002

 

CASH FLOWS FROM OPERATING ACTIVITIES:

                

Net loss

   $ (9,237,596 )   $ (88,813,226 )